Literature DB >> 8623934

Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.

R F Caduff1, C M Johnston, S M Svoboda-Newman, E L Poy, S D Merajver, T S Frank.   

Abstract

Defective DNA mismatch repair in neoplasia is manifested by extra, aberrant bands within multiple microsatellite markers. The replication error (RER) phenotype is present in most colorectal and endometrial carcinomas in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. In addition, a minority of sporadic colorectal and endometrial carcinomas are RER positive. RER in sporadic colorectal carcinomas has been associated with improved prognosis, but its clinical significance in sporadic endometrial cancer has not been characterized. We analyzed DNA extracted from 109 formalin-fixed sporadic endometrial carcinomas for microsatellite instability. The RER-positive phenotype was demonstrated by microsatellite instability in more than one of the eight dinucleotide markers tested. RER was correlated with pathological and clinical parameters as well as with immunohistochemical staining for the p53 gene product and alterations in codon 12 of Ki-ras. Nine percent of the endometrial carcinomas were RER positive, and RER was significantly associated with high grade and adverse outcome. We found no significant correlation of RER with histological subtype, stage, depth of invasion, mutations in the 12th codon of Ki-ras, or p53 immunoreactivity. We conclude that the RER phenotype is present in a minority of sporadic endometrial carcinomas and is associated with high grade and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623934      PMCID: PMC1861548     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Authors:  C A Finlay; P W Hinds; T H Tan; D Eliyahu; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  Genetic mapping of a locus predisposing to human colorectal cancer.

Authors:  P Peltomäki; L A Aaltonen; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; J S Green; J R Jass; J L Weber; F S Leach
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

4.  Expression of p53 and 17p allelic loss in colorectal carcinoma.

Authors:  J Cunningham; J A Lust; D J Schaid; G D Bren; H A Carpenter; E Rizza; J S Kovach; S N Thibodeau
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

5.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Authors:  B J Kerns; P A Jordan; M B Moore; P A Humphrey; A Berchuck; M F Kohler; R C Bast; J D Iglehart; J R Marks
Journal:  J Histochem Cytochem       Date:  1992-07       Impact factor: 2.479

7.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

8.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource.

Authors:  H T Lynch; W Kimberling; W A Albano; J F Lynch; K Biscone; G S Schuelke; A A Sandberg; M Lipkin; E E Deschner; Y B Mikol
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

9.  p53 gene mutations in human endometrial carcinoma.

Authors:  J I Risinger; G A Dent; D Ignar-Trowbridge; J A McLachlan; M S Tsao; M Senterman; J Boyd
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

Review 10.  Genomic instability in neoplasia.

Authors:  R Honchel; K C Halling; S N Thibodeau
Journal:  Semin Cell Biol       Date:  1995-02
View more
  19 in total

1.  Differential vimentin expression in ovarian and uterine corpus endometrioid adenocarcinomas: diagnostic utility in distinguishing double primaries from metastatic tumors.

Authors:  Mohamed M Desouki; Sarah J Kallas; Dineo Khabele; Marta A Crispens; Omar Hameed; Oluwole Fadare
Journal:  Int J Gynecol Pathol       Date:  2014-05       Impact factor: 2.762

2.  K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.

Authors:  G L Mutter; H Wada; W C Faquin; T Enomoto
Journal:  Mol Pathol       Date:  1999-10

3.  Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  D Scott McMeekin; David L Tritchler; David E Cohn; David G Mutch; Heather A Lankes; Melissa A Geller; Matthew A Powell; Floor J Backes; Lisa M Landrum; Richard Zaino; Russell D Broaddus; Nilsa Ramirez; Feng Gao; Shamshad Ali; Kathleen M Darcy; Michael L Pearl; Paul A DiSilvestro; Shashikant B Lele; Paul J Goodfellow
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

4.  Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Israel Zighelboim; Shamshad Ali; Heather A Lankes; Floor Backes; Kathleen Moore; David Mutch; Katina Robison; Kian Behbakht; Steven Waggoner; Rahel G Ghebre; Michael Pearl; Nilsa C Ramirez; Paul Goodfellow
Journal:  Gynecol Oncol       Date:  2015-07-03       Impact factor: 5.482

Review 5.  DNA methylation in endometrial cancer.

Authors:  Meng Hua Tao; Jo L Freudenheim
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

6.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

Authors:  M Esteller; L Catasus; X Matias-Guiu; G L Mutter; J Prat; S B Baylin; J G Herman
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Authors:  J M Cunningham; C Y Kim; E R Christensen; D J Tester; Y Parc; L J Burgart; K C Halling; S K McDonnell; D J Schaid; C Walsh Vockley; V Kubly; H Nelson; V V Michels; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

8.  hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases.

Authors:  J Bischoff; A Ignatov; A Semczuk; C Schwarzenau; T Ignatov; T Krebs; D Küster; D Przadka-Rabaniuk; A Roessner; S D Costa; R Schneider-Stock
Journal:  Clin Exp Metastasis       Date:  2012-05-03       Impact factor: 5.150

9.  Frequent mutations in the RPL22 gene and its clinical and functional implications.

Authors:  Akiva P Novetsky; Israel Zighelboim; Dominic M Thompson; Matthew A Powell; David G Mutch; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2012-11-02       Impact factor: 5.482

Review 10.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.